| Dose | Draw |
|---|---|
| 0.5 mg | 2.5 units |
| 1.0 mg | 5 units |
| 1.5 mg | 7.5 units |
| 2.0 mg Jake | 10 units |
| 2.5 mg Jake | 12.5 units |
| 3.0 mg Jake | 15 units |
| 3.5 mg | 17.5 units |
| 4.0 mg | 20 units |
| 4.5 mg | 22.5 units |
| Dose | Draw |
|---|---|
| 0.5 mg | 5 units |
| 1.0 mg | 10 units |
| 1.5 mg | 15 units |
| 2.0 mg Jake | 20 units |
| 2.5 mg Jake | 25 units |
| 3.0 mg Jake | 30 units |
| 3.5 mg | 35 units |
| 4.0 mg | 40 units |
| 4.5 mg | 45 units |
| Dose | Draw |
|---|---|
| 0.5 mg | 7.5 units |
| 1.0 mg | 15 units |
| 1.5 mg | 22.5 units |
| 2.0 mg Jake | 30 units |
| 2.5 mg Jake | 37.5 units |
| 3.0 mg Jake | 45 units |
| 3.5 mg | 52.5 units |
| 4.0 mg | 60 units |
| 4.5 mg | 67.5 units |
| Period | Dose × Days | Total |
|---|---|---|
| Weeks 1–2 | 2 mg × 2/wk × 2 wks | 8.0 mg |
| Weeks 3–4 | 2.5 mg × 2/wk × 2 wks | 10.0 mg |
| Weeks 5–12 | 3 mg × 2/wk × 8 wks | 48.0 mg |
| Total needed | 66.0 mg | |
Retatrutide is a triple-receptor agonist — it activates three metabolic pathways simultaneously: GLP-1, GIP, and glucagon receptors. This makes it distinct from single-pathway peptides like semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP).
The addition of glucagon receptor activation is what sets retatrutide apart. While GLP-1 and GIP work primarily through appetite suppression and glucose regulation, glucagon signaling directly increases energy expenditure — your body burns more calories at rest. This creates a dual mechanism: you eat less and your metabolism runs hotter.
Appetite changes are typically the first noticeable effect — reduced hunger, earlier fullness, and fewer food cravings. These tend to appear within the first 1–2 weeks. Metabolic effects (increased energy burn) build more gradually over 4–8 weeks as the glucagon pathway upregulates.
Common experiences include mild nausea, changes in bowel habits, and occasional fatigue — especially during the first week after each dose increase. These are dose-dependent and usually resolve as your body adapts. Staying hydrated and eating smaller, more frequent meals helps significantly.
This protocol runs 12 weeks with a structured titration: 2 mg → 2.5 mg → 3 mg, each step held for 2 weeks before advancing. A mid-cycle check-in at week 6 allows us to assess response, adjust if needed, and plan the second half of the cycle. After week 12, we'll evaluate whether to continue, titrate up, or begin a washout period.